The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: Long-term results from a prospective randomized trial

Eva Thomas, Frankie A. Holmes, Terry L. Smith, Aman U. Buzdar, Debra K. Frye, Giuseppe Fraschini, S. Eva Singletary, Richard L. Theriault, Marsha D. McNeese, Frederick Ames, Ronald Walters, Gabriel N. Hortobagyi

Research output: Contribution to journal › Article › peer-review

130 Scopus citations

Fingerprint

Dive into the research topics of 'The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: Long-term results from a prospective randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences